 BOSTON, Jan. 31, 2022 GLOBE NEWSWIRE -- Decibel Therapeutics Nasdaq: DBTX, a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, announced today that it will present findings from its drug discovery and development programs at the 45th Annual MidWinter Meeting of the Association for Research in Otolaryngology ARO, being held virtually February 59, 2022. 